Capricor Therapeutics to Present Exosome Platform Updates at ...

“We continue to build and characterize our StealthX™ exosome platform and this study further supports that endeavor as we provide a novel ...

Capricor Therapeutics to Present Exosome Platform Updates at the ...

The findings highlight a potential exosome-based approach for the treatment of arginase-1 deficiency (ARG1-D), a rare genetic metabolic disease.

Capricor Therapeutics to Present Exosome Platform Updates at 2024 American Association of Extracellular Vesicles Annual Meeting · In This Article ...

Capricor Therapeutics, Inc. (CAPR)

Capricor Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update · Capricor Therapeutics to Present Exosome Platform Updates at ...

Capricor Therapeutics to Present Third Quarter 2024 Financial ...

Capricor is also harnessing the power of its exosome technology, using its proprietary StealthX™ platform in preclinical development focused on ...

Capricor's StealthX Platform Shows Promise in DMD Treatment ...

Capricor Therapeutics (NASDAQ: CAPR) announced the presentation of new preclinical data on their StealthX™ exosome platform at the 2024 ...

Capricor Therapeutics Reports Third Quarter 2024 Financial Results ...

Capricor is also harnessing the power of its exosome technology, using its proprietary StealthX™ platform in preclinical development focused on ...

News & Events :: Capricor Therapeutics, Inc. (CAPR)

Capricor Therapeutics to Present Exosome Platform Updates at 2024 American Association of Extracellular Vesicles Annual Meeting · View All News. Recent Events ...

Capricor Therapeutics to Present Exosome Platform Updates at ...

Sharing and Personal Tools. Please select the service you want to use: Newsvine · Digg · Delicious · StumbleUpon · Technorati · Buzz; Favorites ...

Press Releases :: Capricor Therapeutics, Inc. (CAPR)

Capricor Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update · Capricor Therapeutics to Present Exosome Platform Updates at ...

Capricor Therapeutics to Present at Upcoming Investor and ...

Capricor is also harnessing the power of its exosome technology, using its proprietary StealthX™ platform in preclinical development focused on ...

Capricor Therapeutics to Present Exosome Platform Updates at ...

Capricor Therapeutics to Present Exosome Platform Updates at 2024 American Association of Extracellular Vesicles (AAEV) Annual Meeting.

Capricor Therapeutics to Present Long-Term Data from HOPE-2 ...

Capricor is also harnessing the power of its exosome technology, using its proprietary StealthX™ platform in preclinical development focused on ...

Capricor Therapeutics to Present Exosome Platform Updates at ...

Report. Capricor Therapeutics to Present Exosome Platform Updates at 2024 American Association of Extracellular Vesicles Annual Meeting. r ...

Capricor Therapeutics to Present Exosome Platform Updates at ...

Capricor Therapeutics to Present Exosome Platform Updates at 2024 American Association of Extracellular Vesicles Annual Meeting -Abstract Highlights New ...

Investors :: Capricor Therapeutics, Inc. (CAPR)

Capricor is also developing its exosome technology as a next-generation therapeutic platform. Capricor's current focus is on developing exosomes capable of ...

MarketNews on X: "$CAPR Capricor Therapeutics to Present ...

CAPR Capricor Therapeutics to Present Exosome Platform Updates at 2024 American Association of Extracellular Vesicles Annual Meeting ...

Capricor Therapeutics to Update on Exosome Platform at ASGCT ...

Capricor Therapeutics, a biotech firm at the forefront of cell and exosome-based treatments for rare diseases, has announced a significant ...

Press Releases :: Capricor Therapeutics, Inc. (CAPR)

Capricor Therapeutics to Present Exosome Platform Updates at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting · arrow_back · 1 · 2 · 3 · 4 ...

Capricor Therapeutics announces publication engineered exosome ...

The data was published online in bioRxiv and explored the therapeutic potential of Capricor's proprietary StealthX exosome platform, which ...